Your browser doesn't support javascript.
loading
Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy.
Voorhees, Timothy J; Ghosh, Nilanjan; Grover, Natalie; Block, Jared; Cheng, Catherine; Morrison, Kaitlin; Ivanova, Anastasia; Dotti, Gianpietro; Serody, Jonathan; Savoldo, Barbara; Beaven, Anne W.
Afiliação
  • Voorhees TJ; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Ghosh N; Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Grover N; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Block J; Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Cheng C; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Morrison K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Ivanova A; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Dotti G; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Serody J; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Savoldo B; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
  • Beaven AW; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; and.
Blood Adv ; 4(23): 5925-5928, 2020 12 08.
Article em En | MEDLINE | ID: mdl-33259598

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células T Associado a Enteropatia / Receptores de Antígenos Quiméricos Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Linfoma de Células T Associado a Enteropatia / Receptores de Antígenos Quiméricos Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article